MCF Advisors LLC now owns 4,556 shares of the company's stock valued at $297,000 after purchasing an additional 606 shares in the last quarter. The institutional investor held 111,937 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $9.95M, up from 100,585 at the end of the previous reported quarter. The stock decreased 0.34% or $0.335 during the last trading session, reaching $97.755.
Davis R M Inc. grew its holdings in shares of AbbVie Inc (NYSE:ABBV) by 5.6% during the third quarter, according to the company in its most recent disclosure with the SEC. It has underperformed by 6.07% the S&P500.
TRADEMARK VIOLATION NOTICE: "Gofen & Glossberg LLC IL Has $14.78 Million Stake in AbbVie Inc (ABBV)" was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. Taconic Capital Advisors Lp who had been investing in Bunge Limited for a number of months, seems to be less bullish one the $9.42 billion market cap company.
Timothy J. Richmond Sells 87040 Shares of AbbVie Inc (ABBV) Stock
The stock increased 0.11% or $0.15 during the last trading session, reaching $136.67. About 164,729 shares traded. It is up 14.78% since December 28, 2016 and is uptrending. It has outperformed by 17.82% the S&P500. The rating was maintained by Piper Jaffray with "Buy" on Thursday, August 3. As per Monday, September 25, the company rating was downgraded by UBS.
Investors sentiment increased to 1.21 in 2017 Q3. Its down 0.09, from 0.85 in 2017Q2. 118 funds opened positions while 346 raised stakes. The company had revenue of $6.54 billion during the quarter, compared to analysts' expectations of $6.49 billion. (NYSE:TWX). Lpl Fincl Ltd holds 0.01% or 39,132 shares. Following the completion of the sale, the insider now owns 81,287 shares of the company's stock, valued at approximately $7,360,537.85. Greenwood Gearhart holds 49,813 shares. Coastline Tru Company stated it has 19,600 shares or 0.3% of all its holdings. Hendershot Incorporated accumulated 5.63% or 148,802 shares. Cobblestone Advsrs Limited Liability Corp Ny has 16,460 shares for 0.18% of their portfolio. Lord Abbett & Limited Liability Corporation owns 586,917 shares for 0.32% of their portfolio. Glob X Mngmt Lc holds 1,828 shares.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 83% are positive. Raytheon Company had 67 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Wednesday, April 19 by BMO Capital Markets. BidaskClub raised AbbVie from a "buy" rating to a "strong-buy" rating in a report on Wednesday, September 6th. On Monday, October 31 the stock rating was downgraded by Credit Suisse to "Neutral". American National Bank now owns 2,471 shares of the company's stock worth $161,000 after buying an additional 299 shares during the last quarter. The company was downgraded on Tuesday, December 12 by J.P. Morgan. Jefferies maintained the stock with "Buy" rating in Thursday, August 4 report. On Thursday, August 10 the stock rating was maintained by Robert W. Baird with "Buy". As per Friday, October 13, the company rating was maintained by Barclays Capital.More news: Pfizer Inc. (PFE) Position Lowered by Hamlin Capital Management LLC
AbbVie Inc.by far traveled 65.5% versus a 1-year low price of $59.27. Therefore 36% are positive. Gosebruch Henry O sold $21,127 worth of AbbVie Inc. The stock of AbbVie Inc. (NYSE:TWX). 263 are held by Hanson Mcclain Incorporated. Hudock Capital Group LLC increased its stake in shares of AbbVie by 109.5% in the second quarter. Citigroup upgraded AbbVie Inc. The firm earned "Market Perform" rating on Monday, June 6 by Cowen & Co. (NYSE:ABBV) has "Buy" rating given on Monday, March 7 by Goldman Sachs. As per Thursday, September 1, the company rating was maintained by Cowen & Co. The rating was maintained by BMO Capital Markets on Wednesday, October 11 with "Hold". SunTrust initiated AbbVie Inc. (NYSE:ABBV) rating on Friday, September 15. Morgan Stanley has "Overweight" rating and $73 target. As per Tuesday, March 15, the company rating was initiated by Deutsche Bank.
Water Island Capital Llc, which manages about $3.48B and $2.11B US Long portfolio, upped its stake in Dynegy Inc New Del (NYSE:DYN) by 319,719 shares to 344,719 shares, valued at $3.38 million in 2017Q3, according to the filing. It also reduced Verizon Communications Inc (NYSE:VZ) stake by 28,587 shares and now owns 10,653 shares.
Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings.More news: Pixel C Tablet Dropped From The Google Store
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Sarasin And Ptnrs Ltd Liability Partnership reported 50,000 shares or 0.07% of all its holdings. Great West Life Assurance Co Can holds 0.25% or 969,957 shares. Livforsakringsbolaget Skandia Omsesidigt invested 0.7% of its portfolio in AbbVie Inc. (NYSE:ABBV). Liberty Mutual Gp Asset reported 74,104 shares. Qci Asset Management holds 0% of its portfolio in Time Warner Inc. Mitchell Mcleod Pugh Williams reported 10,427 shares. Franklin Parlapiano Turner & Welch LLC bought a new position in shares of AbbVie in the first quarter worth about $108,000. Professional Advisory invested in 3,000 shares or 0.06% of the stock. Lederer And Associates Inv Counsel Ca accumulated 30,080 shares. Fifth Third Bancorporation invested 0.9% of its portfolio in AbbVie Inc. Cincinnati Specialty Underwriters has 27,200 shares. Noting its average daily volume at 5.52 million shares each day over the month, this signifies a pretty significant change over the norm. This is a boost from AbbVie's previous quarterly dividend of $0.64.
Since July 31, 2017, it had 0 insider purchases, and 8 insider sales for $45.57 million activity. RICHMOND TIMOTHY J. sold 87,040 shares worth $8.57 million. $6.24 million worth of AbbVie Inc. 8,300 shares were sold by SALEKI-GERHARDT AZITA, worth $705,655.
Analysts await AbbVie Inc. (NYSE:ABBV). Voya Limited Liability Co reported 770,953 shares. They expect $1.63 EPS, down 4.12% or $0.07 from last year's $1.7 per share. The firm has a market capitalization of $104.37 billion, a P/E ratio of 17.00 and a beta of 1.57.More news: Technical Spotlight: Tracking Shares of S&P 500 Telecom Sector SPDR (XTL)
Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.